CD4 + T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Cryptococcus neoformans is a major fungal pathogen that disseminates to the central nervous system (CNS) to cause fatal meningoencephalitis, but little is known about immune responses within this immune-privileged site. CD4 + T cells have demonstrated roles in anticryptococcal defenses, but increasing evidence suggests that they may contribute to clinical deterioration and pathology in both HIV-positive (HIV+) and non-HIV patients who develop immune reconstitution inflammatory syndrome (IRIS) and post-infectious inflammatory response syndrome (PIIRS), respectively. Here we report a novel murine model of cryptococcal meningoencephalitis and a potential damaging role of T cells in disseminated cryptococcal CNS infection. In this model, fungal burdens plateaued in the infected brain by day 7 postinfection, but activation of microglia and accumulation of CD45 hi leukocytes was significantly delayed relative to fungal growth and did not peak until day 21. The inflammatory leukocyte infiltrate consisted predominantly of gamma interferon (IFN-γ)-producing CD4 + T cells, conventionally believed to promote fungal clearance and recovery. However, more than 50% of mice succumbed to infection and neurological dysfunction between days 21 and 35 despite a 100-fold reduction in fungal burdens. Depletion of CD4 + cells significantly impaired IFN-γ production, CD8 + T cell and myeloid cell accumulation, and fungal clearance from the CNS but prevented the development of clinical symptoms and mortality. These findings conclusively demonstrate that although CD4 + T cells are necessary to control fungal growth, they can also promote significant immunopathology and mortality during CNS infection. The results from this model may provide important guidance for development and use of anti-inflammatory therapies to minimize CNS injury in patients with severe cryptococcal infections. IMPORTANCE CNS infection with the fungal pathogen Cryptococcus neoformans often results in debilitating brain injury and has a high mortality rate despite antifungal treatment. Treatment is complicated by the fact that immune responses needed to eliminate infection are also thought to drive CNS damage in a subset of both HIV+ and non-HIV patients. Thus, physicians need to balance efforts to enhance patients’ immune responses and promote microbiological control with anti-inflammatory therapy to protect the CNS. Here we report a novel model of cryptococcal meningoencephalitis demonstrating that fungal growth within the CNS does not immediately cause symptomatic disease. Rather, accumulation of antifungal immune cells critically mediates CNS injury and mortality. This model demonstrates that antifungal immune responses in the CNS can cause detrimental pathology and addresses the urgent need for animal models to investigate the specific cellular and molecular mechanisms underlying cryptococcal disease in order to better treat treat patients with CNS infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis
Kim, J. V., Kang, S. S., Dustin, M. L., & McGavern, D. B. (2009) · Nature · doi:10.1038/nature07591 · Cited by 326 · cited 1×
“neoformans meningoencephalitis are supported by notable damaging roles of CD4 and CD8 T cells in the CNS during infections, including cerebral malaria (63–65), viral encephalitis (66), toxoplasmosis (67–69), tuberculosis meningitis (27), and immunological disorders such as multiple sclerosis (70).”
BackgroundEpidemiology of cryptococcal meningitis in the US: 1997–2009
Pyrgos, V., Seitz, A. E., Steiner, C. A., Prevots, D. R., & Williamson, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056269 · Cited by 309
Self-citationJarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Pathogenesis of Cerebral Cryptococcus neoformans Infection after Fungemia
Chrétien, F., Lortholary, O., Kansau, I., Neuville, S., Gray, F., & Dromer, F. (2002) · The Journal of Infectious Diseases · doi:10.1086/341564 · Cited by 201
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis
Panackal, A. A., Wuest, S. C., Lin, Y.-C., Wu, T., Zhang, N., Kosa, P., Komori, M., Blake, A., Browne, S. K., Rosen, L. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004884 · Cited by 162
Self-citationWozniak, K. L., Ravi, S., Macias, S., Young, M. L., Olszewski, M. A., Steele, C., & Wormley, F. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006854 · Cited by 99
Self-citationProtective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice
Wozniak, K. L., Young, M. L., & Wormley, F. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00036-11 · Cited by 72
Cited by
Mechanisms of Cryptococcus neoformans-Mediated Host Damage
Casadevall, A., Coelho, C., & Alanio, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00855 · Cited by 90
“neoformans infections, host damage can come from both the microbe, as reviewed in this essay, and from the immune response (3, 4, 75).”
BackgroundInfluentialEfficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
Lu, R., Hollingsworth, C., Qiu, J., Wang, A., Hughes, E., Xin, X., Konrath, K. M., Elsegeiny, W., Park, Y.-D., Atakulu, L., et al. (2019) · mBio · doi:10.1128/mbio.00724-19 · Cited by 67
“…or result in inflammatory syndromes, similar to cryptococcal immune reconstitution inflammatory syndrome (cIRIS) after antiretroviral therapy (ART) in HIV-related disease or a postinfectious inflammatory syndrome in non-HIV patients (15, 29, 30) which is also present during murine infections (31).”
Self-citationSun, D., Zhang, M., Sun, P., Liu, G., Strickland, A. B., Chen, Y., Fu, Y., Yosri, M., & Shi, M. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008361 · Cited by 34
Metadata
- Authors
- Neal, L. M., Xing, E., Xu, J., Kolbe, J. L., Osterholzer, J. J., Segal, B. M., Williamson, P. R., & Olszewski, M. A.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2017-12-29
- Volume
- 8
- Issue
- 6
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2770408307
- Cited by
- 110
- References
- 9
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.